Drug intelligence / Profile preview

varicella vaccine, live

Development stage
Approved
Lead developer
Shanghai Rongsheng Biotech
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Varicella vaccine, live is a live-attenuated viral vaccine developed by Shanghai Rongsheng Biopharmaceutical Co., Ltd. for the prevention of varicella (chickenpox) caused by the varicella-zoster virus (VZV). The vaccine is typically based on the Oka strain of VZV, which has been attenuated through serial passage in various cell cultures. Upon administration, the attenuated virus undergoes limited replication, mimicking a natural infection to stimulate the production of VZV-specific antibodies and activate cell-mediated immunity (T-cell response). This provides long-term protection against primary infection and reduces the severity of the disease if breakthrough infection occurs. It is primarily indicated for children, adolescents, and susceptible adults.

Brand names
BCHT Varicella Vaccine
Other names
varicella virus vaccine, live attenuatedchickenpox vaccineOka strain varicella vaccine

Beyond the preview

Go deeper on varicella vaccine, live.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on varicella vaccine, live.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call